Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark Forman
Mark Forman
Merck & Co.
Diabetes mellitus
Medicine
Verubecestat
Amyloid
Psychiatry
3
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AN INTEGRATED MECHANISTIC AMYLOID PATHWAY MODEL INFORMED BY CLINICAL BIOMARKER DATA FROM VERUBECESTAT AND OTHER BACE INHIBITORS
2019
Alzheimers & Dementia
Christian Rasmussen
Huub-Jan Kleijn
Juliya Kalinina
Marissa Dockendorf
Mary J. Savage
Arie Struyk
Mark Forman
Julie A. Stone
Show All
Source
Cite
Save
Citations (0)
Safety, Tolerability, and Pharmacokinetics of the β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor Verubecestat (MK-8931) in Healthy Elderly Male and Female Subjects
2019
Clinical and Translational Science
Mark Forman
John Palcza
Jack Tseng
Julie A. Stone
Brittany Walker
Dennis Swearingen
Matthew D. Troyer
Marissa Dockendorf
Show All
Source
Cite
Save
Citations (5)
Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
2017
Alzheimers & Dementia
Gil D. Rabinovici
Maria C. Carrillo
Mark Forman
Susan DeSanti
David S. Miller
Nicholas Kozauer
Ronald C. Petersen
Christopher Randolph
David S. Knopman
Eric E. Smith
Maria Isaac
Niklas Mattsson
Lisa J. Bain
James A. Hendrix
John R. Sims
Show All
Source
Cite
Save
Citations (9)
1